Merit Medical Systems (NASDAQ:MMSI) will be issuing its quarterly earnings data after the market closes on Monday, February 19th. Analysts expect the company to announce earnings of $0.32 per share for the quarter.
Shares of Merit Medical Systems (MMSI) opened at $42.65 on Monday. Merit Medical Systems has a 12 month low of $27.08 and a 12 month high of $48.10. The company has a market capitalization of $2,140.99, a price-to-earnings ratio of 69.92, a PEG ratio of 2.53 and a beta of 1.29. The company has a quick ratio of 1.43, a current ratio of 2.78 and a debt-to-equity ratio of 0.39.
In related news, Director Franklin J. Miller sold 10,000 shares of the business’s stock in a transaction on Friday, December 29th. The stock was sold at an average price of $43.93, for a total transaction of $439,300.00. Following the completion of the transaction, the director now owns 21,244 shares in the company, valued at approximately $933,248.92. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Kent W. Stanger sold 9,082 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $44.90, for a total value of $407,781.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 32,000 shares of company stock valued at $1,416,379. 5.00% of the stock is owned by company insiders.
WARNING: “Merit Medical Systems (MMSI) to Release Quarterly Earnings on Monday” was posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/02/12/merit-medical-systems-mmsi-to-release-quarterly-earnings-on-monday.html.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.